Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06216886 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

OnabotulinumtoxinA for Trigeminal Neuralgia

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Feb 1, 2026 to Feb 1, 2027
    • Study completion date: Sep 1, 2026 to Sep 1, 2027
    v4
  2. Primary completion date: Feb 1, 2025 to Feb 1, 2026
    • Study completion date: Sep 1, 2025 to Sep 1, 2026
    v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 1, 2024 to Jun 1, 2024
    • Site details revised
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A randomized controlled trial comparing Onabotulinumtoxin A to saline (placebo) for Trigeminal Neuralgia.
Trial Details
NCT Number NCT06216886
Lead Sponsor Stanford University
Conditions
(from sponsor)		 Trigeminal Neuralgia
Related terms Trigeminal Neuralgia
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov